20th - 23rd October 2020

Biomarker and Companion Diagnostics Virtual Conference (EST TIME ZONE)

Leveraging next gen technologies beyond conventional biomarker drug discovery

The emergence of the need for safety and efficacy of a drug subjected to individual patients has made companion diagnostics one of the most sought after topics in the field of In-Vitro Diagnostics. The surge of investment in companion diagnostics has brought forward issues regarding regulations and their intricacies and boosted new trends in immuno-oncology, immuno-therapies, data interpretation and unconventional design of clinical trials.

The Biomarker and Companion Diagnostics Virtual Conference scheduled to be held on 20-23 October 2020 would address the gaps between early-stage biomarker development and the commercialization stage of biomarkers.

This conference would also highlight case studies on leveraging emerging technologies in Digital Biomarkers, Precision Medicine and Big Data. Regarding the commercialization of biomarkers, leading industry and academic experts would share their case studies focusing on advancements in the companion diagnostics area. The keynote presentations would also help the attendees understand the issues related to the clinical translation of biomarkers.

WHAT TO EXPECT
Key Highlights
  • Commercialization of CDx
  • Proteomics and Genomics based Biomarkers
  • Biomarker Drug Discovery and Assay Development
  • Multiplex Companion Diagnostics and Regulatory Guidelines
  • Design of clinical trials in CDx
  • Digital Biomarkers, Predictive Biomarkers, Precision Medicine and Big Data
  • Clinical Applications of Biomarkers in Immuno-Oncology, Neurology and Inflammatory Diseases
Who Should Attend?

Researchers, scientists, clinicians, academicians and professionals from Pharmaceutical companies, Bio-pharma companies & Universities and Research institutes working in:

  • Biomarker discovery/development
  • Translational research
  • Clinical Biomarker
  • Biomarkers in IO and Neurological disorders
  • Imaging Biomarkers
  • Pathology
  • Companion Diagnostics
  • Biomarker Imaging
  • Proteomics Biomarkers
  • Experimental Medicine
  • Data Science
  • Biomarkers in Clinical Discovery
  • Immuno-oncology/Neuroscience Drug Discovery
  • Diagnostic Biomarkers development
  • Personalized Medicine
  • Immunology Biomarkers
CONFERENCE SPEAKERS
Speakers
Roy Baynes

Roy Baynes

Senior Vice President and Head, Global Clinical Development, Chief Medical Officer
Merck Research Laboratories

Roy Baynes

Senior Vice President and Head, Global Clinical Development, Chief Medical Officer
Merck Research Laboratories
John Rossi

John Rossi

Director, Translational Sciences
Kite Pharma

John Rossi

Director, Translational Sciences
Kite Pharma
Mike Baratta

Mike Baratta

Scientific Director, Translational Biomarker Research
Takeda

Mike Baratta

Scientific Director, Translational Biomarker Research
Takeda
Pallavi Sachdev

Pallavi Sachdev

Senior Director, Clinical Pharmacology and Translational Medicine
Eisai

Pallavi Sachdev

Senior Director, Clinical Pharmacology and Translational Medicine
Eisai
Adil Daud

Adil Daud

Clinical Professor
UCSF

Adil Daud

Clinical Professor
UCSF
Majid Ghoddusi

Majid Ghoddusi

Senior Director, Clinical Biomarkers
Poseida Therapeutics

Majid Ghoddusi

Senior Director, Clinical Biomarkers
Poseida Therapeutics
Kevin Wang

Kevin Wang

Director, Program for Neuroproteomics and Biomarkers Research
University of Florida

Kevin Wang

Director, Program for Neuroproteomics and Biomarkers Research
University of Florida
Dr. Ian Pike

Dr. Ian Pike

Chief Scientific Officer
Proteome Sciences PLC

Dr. Ian Pike

Chief Scientific Officer
Proteome Sciences PLC
SPONSORS
Platinium
example-image

QIAGEN

Gold
example-image

Burning Rock

example-image

Owlstone Medical

example-image

Agilent

Silver
example-image

Larvol

Sponsors & Exhibitors
example-image

Proteome Sciences

Speaking Partner
example-image

NeoGenomics

Meeting Partner
example-image

International Drug Development Institute

PAST EVENT GALLERY